GLPBio

Estrogen/progestogen Receptor

The estrogen/progestogen receptors are activated by the hormone estrogen/progesterone and regulate the gene transcription.

Products Related to Estrogen/progestogen Receptor(156)

  • GC48979 structure
    GC48979Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate)
    Purity: >95.00%

    A substrate of multidrug resistance protein 2

  • GC49025 structure
    GC49025Desogestrel-13C2-d2
    Purity: >99.00%

    An internal standard for the quantification of desogestrel

  • GC49068 structure
    GC4906816-Epiestriol
    CAS: 547-81-9
    Purity: >90.00%

    A metabolite of estrone

  • GC49161 structure
    GC4916116α-hydroxy Dehydroepiandrosterone
    CAS: 1232-73-1
    Purity: >95.00%

    A metabolite of dehydroepiandrosterone

  • GC49172 structure
    GC491722-hydroxy Estrone
    CAS: 362-06-1
    Purity: >95.00%

    An active metabolite of estrone

  • GC49189 structure
    GC49189(E/Z)-4-hydroxy Tamoxifen-d5
    CAS: 2470232-57-4
    Purity: >99.00%

    An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen

  • GC49254 structure
    GC49254Estrone-3-Glucuronide (sodium salt hydrate)
    Purity: >98.00%

    A metabolite of 17β-estradiol

  • GC49326 structure
    GC493265β-Dihydroprogesterone
    CAS: 128-23-4
    Purity: >95.00%

    A progesterone receptor agonist and metabolite of progesterone

  • GC49391 structure
    GC493917α-Thiospironolactone
    CAS: 38753-76-3
    Purity: >90.00%

    An active metabolite of spironolactone

  • GC49520 structure
    GC49520(S)-Equol
    CAS: 531-95-3
    Purity: >99.00%

    (S)-Equol is an isoflavone compound produced by the gut microbiota of some individuals, primarily derived from the metabolism of daidzein in soybeans by specific gut bacteria. (S)-Equol exhibits significant estrogenic activity and antioxidant properties, binding to estrogen receptors with an affinity for ERβ of Ki=0.73±0.2nM and for ERα of Ki=6.41±1nM.

  • GC49562 structure
    GC495624-methoxy Estrone
    CAS: 58562-33-7
    Purity: >95.00%

    An active metabolite of estrone

  • GC49563 structure
    GC49563Fenhexamid
    CAS: 126833-17-8
    Purity: >98.00%

    Fenhexamid, a botryticide, is a sterol biosynthesis inhibitor.

  • GC49609 structure
    GC496092-bromo 17β-Estradiol
    CAS: 15833-07-5
    Purity: >98.00%

    A synthetic steroid and inhibitor of estrogen 2-hydroxylase

  • GC49757 structure
    GC49757Bazedoxifene N-oxide
    CAS: 1174289-22-5
    Purity: >90.00%

    An oxidative degradation product of bazedoxifene

  • GC49848 structure
    GC4984816-Ketoestradiol
    CAS: 566-75-6
    Purity: >95.00%

    An active metabolite of estrone

  • GC49878 structure
    GC49878Fulvestrant 9-sulfone
    CAS: 98008-06-1
    Purity: >98.00%

    An estrogen receptor antagonist and a derivative of fulvestrant

  • GC50091 structure
    GC50091AC 186
    CAS: 1421854-16-1
    Purity: >98%

    Potent and selective ERβ agonist; neuroprotective

  • GC52180 structure
    GC52180WAY-169916
    CAS: 669764-18-5
    Purity: >98.00%

    WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity.

  • GC52189 structure
    GC52189Nomegestrol
    CAS: 58691-88-6
    Purity: >95.00%

    Nomegestrol is a potent and orally available progestin, acts as a selective full progesterone receptor agonist, with a Kd of 5.44 nM for rat uterine progesterone receptor, and has moderate antiandrogenic activity and strong antiestrogenic activity.

  • GC52365 structure
    GC523654-tert-Octylphenol monoethoxylate
    CAS: 2315-67-5
    Purity: >98.00%

    An alkylphenolethoxylate and a degradation product of non-ionic surfactants

  • GC52420 structure
    GC52420Drospirenone-13C3
    Purity: >95.00%

    An internal standard for the quantification of drospirenone

  • GC61267 structure
    GC61267SAR439859
    CAS: 2114339-57-8
    Purity: >99.50%

    SAR439859 (compound 43d) is an orally active, nonsteroidal and selective estrogen receptor degrader (SERD). SAR439859 is a potent ER antagonist and has ER degrading activity with an EC50 of 0.2 nM for ERα degradation. SAR439859 demonstrates robust antitumor efficacy and limited cross-resistance in ER+ breast cancer.

  • GC61971 structure
    GC61971Liarozole
    CAS: 115575-11-6
    Purity: >98.50%

    Liarozole (R75251; R85246) is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA).

  • GC62061 structure
    GC62061Melengestrol acetate
    CAS: 2919-66-6
    Purity: >99.50%

    Melengestrol acetate is a progesterone derivative, acts as an orally active corticosteroid hormone to promote endometrial proliferation, pregnancy maintenance, and delay of menstrual activity.